Nizatidine

尼扎替丁

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNizatidine
Drug Alias Namenizatidina尼沙替丁尼紮替丁nizatidinum尼刹替丁 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsHeartburnDyspepsiaStomach Ulcer +[6] 
Global Approved IndicationsHeartburnStomach UlcerDuodenal Ulcer +[5] 
Approved Indications in ChinaHeartburnStomach UlcerDuodenal Ulcer +[5] 
Original Approved Country/TerritoryUnited States
Original Approved Date1988/04/12
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLCLilly Del Caribe Inc
Inactive CompaniesSmithkline Beecham (Cork) LtdBraintree Laboratories IncDr.Reddy's Laboratories Ltd +[5] 
Active IndicationsHeartburnDyspepsiaStomach Ulcer +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BA04
Related LinksWikipediaDrugBankKEGG